Tourmaline Bio, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRML research report →
Companywww.tourmalinebio.com
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED).
- CEO
- Sandeep C. Kulkarni
- IPO
- 2021
- Employees
- 74
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $1.23B
- P/E
- -18.09
- P/S
- 30816.28
- P/B
- 4.77
- EV/EBITDA
- -16.88
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 20.00%
- Op Margin
- -195027.50%
- Net Margin
- -170742.50%
- ROE
- -24.42%
- ROIC
- -30.08%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-73,210,000 · -73.80%
- EPS
- $-2.89 · 67.42%
- Op Income
- $-89,732,000
- FCF YoY
- -174.63%
Performance & Tape
- 52W High
- $48.27
- 52W Low
- $11.56
- 50D MA
- $40.68
- 200D MA
- $22.74
- Beta
- 1.58
- Avg Volume
- 925.78K
Get TickerSpark's AI analysis on TRML
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 28, 25 | SIEGALL CLAY B | sell | 16,800 |
| Oct 28, 25 | SIEGALL CLAY B | sell | 15,000 |
| Oct 28, 25 | SIEGALL CLAY B | sell | 20,000 |
| Oct 28, 25 | Thiara Parvinder | sell | 16,800 |
| Oct 28, 25 | Thiara Parvinder | other | 83,782 |
| Oct 28, 25 | Thiara Parvinder | sell | 10,000 |
| Oct 28, 25 | Thiara Parvinder | sell | 10,000 |
| Oct 28, 25 | Srivastava Sapna | sell | 20,000 |
| Oct 28, 25 | Srivastava Sapna | sell | 16,800 |
| Oct 28, 25 | Srivastava Sapna | sell | 10,000 |
Our TRML Coverage
We haven't published any research on TRML yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TRML Report →